ALKBH1 and glioblastoma: By taking advantage of the abundant bioinformatics databases (Table 1), we performed a comprehensive analysis of the AlkB family in GBM, and managed to identify the significant prognostic hallmarks and therapeutic targets within this family, which we believe could help clinicians precisely predict patient survival and select alternative therapeutic drugs.